Skip to main content

Table 2 Model of HbA1c values of participants by treatment

From: Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: a randomized controlled trial

Model parameter

b(SE)

95% CI

Z

P-value

Fixed effects

b0 (intercept)

9.029 (0.144)

8.746, 9.312

62.52

<0.001

b1 (Time)

-0.002 (0.001)

-0.004, -0.001

-3.13

0.002

b2 (Time2)

1.70 × 10-6 (2.27 × 10-6)

-2.75 × 10-6, 6.16 × 10-6

0.75

0.453

b3 (CDSMP)

0.114 (0.201)

-0.280, 0.508

0.57

0.571

b4 (PDA)

0.054 (0.214)

-0.366, 0.473

0.25

0.802

b5 (CDSMP + PDA)

-0.121 (0.204)

-0.520, 0.278

-0.60

0.551

b6 (CDSMP × Time)

-0.001 (0.001)

-0.003, 0.001

-1.17

0.242

b7 (PDA × Time)

7.22 × 10-5 (0.001)

-0.002, 0.002

0.06

0.950

b8 ((CDSMP + PDA) × Time)

-0.001 (0.001)

-0.003, 0.002

-0.61

0.543

b9 (CDSMP × Time2)

4.63 × 10-6 (3.16 × 10-6)

-1.55 × 10-6, 1.08 × 10-5

1.47

0.142

b10 (PDA × Time2)

2.04 × 10-6 (3.64 × 10-6)

-5.09 × 10-6, 9.17 × 10-6

0.56

0.575

b11 ((CDSMP + PDA) × Time2)

5.21 × 10-6 (3.47 × 10-6)

-1.59 × 10-6, 1.20 × 10-5

1.50

0.133

Random effects

var(u 1it × time it )

0.002 (2.59 × 10-4)

0.002, 0.003

9.30

<0.001

var(u 0i )

1.257 (0.056)

1.153, 1.372

22.53

<0.001

var(e it )

0.870 (0.024)

0.825, 0.918

36.39

<0.001